Today's Top early Lunchtime Stocks: XERI, DGLY, QNRX, IBG, CNTM, and SBFM

2025-04-02 10:51:39 ET

DENVER, Colo., Apr 02, 2025 ( 247marketnews.com )- Xeriant (OTCQB:XERI) named Mark Sternberg, a nanomaterial maestro, to its Board of Directors. Sternberg’s arrival turbocharges Xeriant’s push to commercialize NEXBOARD™, its eco-friendly nanocomposite panel, at a moment when the company’s hitting peak stride.

Sternberg carved a legacy in nanotechnology, steering product development, manufacturing, and sales, over his 30-year career. As CEO of Moyco Precision Abrasives, he pioneered nanomaterial coatings and submicron abrasives, clinching a sale to Saint-Gobain, a $50 billion titan in industrial materials. Post-deal, he ran sales for Saint-Gobain’s $2 billion Abrasives division.

The move follows NEXBOARD building panel’s, forged from recycled plastic and fiber waste to outmuscle drywall and plywood, recent in-house 15 minutes of flame resistance test.

Digital Ally (NASDAQ:DGLY) is today’s most active stock, based on trading volume, and has an interesting gap from 11-cents to 15-cents.

Quoin Pharmaceuticals (NASDAQ:QNRX) reported stunning results from its ongoing pediatric Netherton Syndrome (NS) study. Six weeks into whole-body treatment with QRX003, a topical lotion targeting this rare skin disorder, the first young patient’s skin is nearly healed; a visual stunner that’s holding strong with daily dosing. This could be a lifeline for kids battling a disease with no cure or approved fix.

Beyond the durable healing, the patient’s ditched a cocktail of meds—antibiotics, antivirals, antihistamines, glucocorticoids—once staples for her fragile skin. Her pruritus (itch) Almost gone, delivering zero nightly sleep disruptions; a first in her life, no sedatives needed. There were no adverse events after six weeks of QRX003 use.

Regulators just greenlit testing on a second pediatric patient, doubling down on this estimated $1 billion rare disease market.

Innovation Beverage (NASDAQ:IBG) is currently trading at more than triple yesterday’s closing price and, more importantly, has cleared November’s price levels.

ConnectM Techn (NASDAQ:CNTM) reported receiving a non-binding offer to acquire all remaining outstanding CNTM shares for $1.60 per share in cash from its three largest institutional investors—SriSid LLC, Arumilli LLC, and Win-Light Global Co. Ltd.—and transition ConnectM into a privately held entity.

Sunshine Biopharma (NASDAQ:SBFM) is trading higher after publishing its 2024 financial results.

Please go to https://www.247marketnews.com/disclaimer/ or Xeriant lander for disclaimer information

The post Today’s Top early Lunchtime Stocks: XERI, DGLY, QNRX, IBG, CNTM, and SBFM appeared first on 24/7 MarketNews .

For further details see: